[1] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南.实用肝脏病杂志,2013,16（3）：210-216.
[2] Devarbhavi H,Dierkhising R,Kremers WK,et al. Single-center experience with drug-induced liver injury from India:causes,outcome,prognosis and predictors of mortality. Am J Gastroenterol,2010,105（11）∶2396-2404.
[3] 段钟平,陈煜.人工肝的临床应用.中华肝脏病杂志,2010,18（11）:808-810.
[4] 李兰娟. 肝衰竭诊疗进展.中华肝脏病杂志,2010,18（11）:801-802. [5] Okuyama H,Kimura S,Fujimoto K,et al. A case of chronic hepatitis C with nephrotic diabetic nephropathy who achieved sustained viral remission by double-filtration plasmapheresis and interferon combination therapy. Intern Med,2012,51（15）:1991-1995.
[6] Podoll AS,DeGolovine A,Finkel KW. et al. Liver support systems—a review. ASAIO J,2012,58（5）:443-449.
[7] Morgan SM,Zantek ND. Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson's disease. J Clin Apher,2012,27（5）:282-286.
[8] Jin F,Cao M,Bai Y,et al. Therapeutic effects of plasma exchange for the treatment of 39 patients with acute fatty liver of pregnancy. Discov Med,2012,13（72）:369-373.
[9] Yoffe IV,Poteriakhin VN. Application of plasmapheresis in postoperative period in patients,suffering obturation jaundice. Klin Khir,2012,23（2）:36-38.
[10] Huang YK,Tan DM,Xie YT,et al. Randomized controlled study of plasma exchange combined with molecular adsorbent re-circulating system for the treatment of liver failure complicated with hepatic encephalopathy. Hepatogastroenterology,2012,59（117）:1323-1326. |
